LSI USA '23 filling fast. Register Now

Iomed (Acquired)

Noninvasive, site-specific drug delivery technology to deliver compounds to the posterior segments of the eye

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Iomed (Acquired) plus 5403 other startups.

Start Free 7 Day Trial Now

Learn More About Iomed (Acquired)

Technology/product details

Competing Startups

More

Our Clients